| Directors |
|
|
|
|
| Company Number |
|
| Registered Office | Unit 4 Prenton Way |
| North Cheshire Trading Estate | |
| Prenton | |
| CH43 3EA | |
| Auditors |
|
| Chartered Certified Accountants | |
| 56 Upper English Street | |
| Armagh | |
| Co. Armagh | |
| BT61 7LG | |
|
2025
|
2024
|
|
|
Turnover
|
10,625,193
|
8,320,482
|
|
GP %
|
21.0%
|
17.4%
|
|
NP %
|
0.4%
|
4.2%
|
|
PAT %
|
0.3%
|
3.6%
|
|
Current Ratio
|
0.79 : 1
|
1.68 : 1
|
|
Director
|
|
16/06/2026
|
|
|
|
|
|
Director
|
|
|
|
for and on behalf of
|
|
|
|
Chartered Certified Accountants
56 Upper English Street
Armagh
Co. Armagh
BT61 7LG
|
| 2025 | 2024 | |||
|---|---|---|---|---|
| Notes | £ | £ | ||
| TURNOVER | 3 |
|
|
|
| Cost of sales |
( |
( |
||
| GROSS PROFIT |
|
|
||
| Administrative expenses |
( |
( |
||
| Other operating income |
|
|
||
| OPERATING PROFIT | 4 |
|
|
|
| Interest payable and similar charges | 9 |
( |
|
|
| PROFIT BEFORE TAXATION |
|
|
||
| Tax on Profit | 10 |
( |
( |
|
| PROFIT AFTER TAXATION BEING PROFIT FOR THE FINANCIAL YEAR |
|
|
||
| 2025 | 2024 | |||
|---|---|---|---|---|
| £ | £ | |||
| PROFIT FOR THE FINANCIAL YEAR |
|
|
||
| OTHER COMPREHENSIVE INCOME FOR THE YEAR | - | - | ||
| TOTAL COMPREHENSIVE INCOME FOR THE YEAR |
|
|
||
| 2025 | 2024 | ||||
|---|---|---|---|---|---|
| Notes | £ | £ | £ | £ | |
| FIXED ASSETS | |||||
| Intangible Assets | 11 |
|
|
||
| Tangible Assets | 12 |
|
|
||
| Investments | 13 |
|
|
||
|
|
|
||||
| CURRENT ASSETS | |||||
| Stocks | 14 |
|
|
||
| Debtors | 15 |
|
|
||
| Cash at bank and in hand |
|
|
|||
|
|
|
||||
| Creditors: Amounts Falling Due Within One Year | 16 |
( |
( |
||
| NET CURRENT ASSETS (LIABILITIES) |
( |
|
|||
| TOTAL ASSETS LESS CURRENT LIABILITIES |
|
|
|||
| Creditors: Amounts Falling Due After More Than One Year | 17 |
( |
( |
||
| PROVISIONS FOR LIABILITIES | |||||
| Deferred Taxation | 20 |
( |
|
||
| NET ASSETS |
|
|
|||
| CAPITAL AND RESERVES | |||||
| Called up share capital | 22 |
|
|
||
| Profit and Loss Account |
|
|
|||
| SHAREHOLDERS' FUNDS | 335,309 | 302,199 | |||
|
Director
|
|
|
| Share Capital | Profit and Loss Account | Total | |
|---|---|---|---|
| £ | £ | £ | |
| As at 1 July 2023 |
|
|
1 |
| Profit for the year and total comprehensive income | - |
|
302,198 |
| As at 30 June 2024 and 1 July 2024 |
|
|
302,199 |
| Profit for the year and total comprehensive income | - |
|
33,110 |
| As at 30 June 2025 |
|
|
335,309 |
| Leasehold |
|
| Fixtures & Fittings |
|
| Right of Use |
|
| 2025 | 2024 | ||
|---|---|---|---|
| £ | £ | ||
| United Kingdom |
|
|
|
| Europe |
|
|
|
| Rest of the world |
|
|
|
| 10,625,193 | 8,320,482 | ||
| 2025 | 2024 | ||
|---|---|---|---|
| £ | £ | ||
| Depreciation of tangible fixed assets |
|
|
|
| 2025 | 2024 | ||
|---|---|---|---|
| £ | £ | ||
| Audit Services | |||
| Audit of the company's financial statements |
|
|
|
| 2025 | 2024 | ||
|---|---|---|---|
| £ | £ | ||
| Wages and salaries |
|
|
|
| Social security costs |
|
|
|
|
|
|
||
| 2025 | 2024 | ||
|---|---|---|---|
| Office and administration |
|
|
|
|
|
|
||
| 2025 | 2024 | ||
|---|---|---|---|
| £ | £ | ||
| Emoluments |
|
|
|
| 2025 | 2024 | ||
|---|---|---|---|
| £ | £ | ||
| Emoluments |
|
|
|
| 2025 | 2024 | ||
|---|---|---|---|
| £ | £ | ||
| Bank loans and overdrafts |
|
|
|
| Foreign exchange charges |
( |
|
|
| Other finance charges |
|
|
|
| 188,648 | - | ||
| Tax Rate | 2025 | 2024 | |||
|---|---|---|---|---|---|
| 2025 | 2024 | £ | £ | ||
| Current tax | |||||
| UK Corporation Tax | 25.0% | 25.0% |
|
|
|
| Deferred Tax | |||||
| Deferred taxation |
|
|
|||
| Total tax charge for the period |
|
|
|||
| 2025 | 2024 | ||||
|---|---|---|---|---|---|
| £ | £ | ||||
| Profit before tax | 42,038 | 350,233 | |||
| Tax on profit at 25% (UK standard rate) |
|
|
|||
| Goodwill/depreciation not allowed for tax |
|
|
|||
| Expenses not deductible for tax purposes |
|
|
|||
| Tax losses utilised |
( |
|
|||
| Capital allowances |
( |
|
|||
| Short term timing differences |
|
|
|||
| Research and Development tax credit |
|
( |
|||
| Total tax charge for the period | 8,928 | 48,035 | |||
| Goodwill | |||
|---|---|---|---|
| £ | |||
| Cost | |||
| As at 1 July 2024 |
|
||
| As at 30 June 2025 |
|
||
| Net Book Value | |||
| As at 30 June 2025 |
|
||
| As at 1 July 2024 |
|
||
| Land & Property | ||||
|---|---|---|---|---|
| Leasehold | Fixtures & Fittings | Right of Use | Total | |
| £ | £ | £ | £ | |
| Cost | ||||
| As at 1 July 2024 |
|
|
|
|
| Additions |
|
|
|
|
| As at 30 June 2025 |
|
|
|
|
| Depreciation | ||||
| As at 1 July 2024 |
|
|
|
|
| Provided during the period |
|
|
|
|
| As at 30 June 2025 |
|
|
|
|
| Net Book Value | ||||
| As at 30 June 2025 |
|
|
|
|
| As at 1 July 2024 |
|
|
|
|
| Subsidiaries | |
|---|---|
| £ | |
| Cost or Valuation | |
| As at 1 July 2024 |
|
| Additions |
|
| As at 30 June 2025 |
|
| Provision | |
| As at 1 July 2024 |
|
| As at 30 June 2025 |
|
| Net Book Value | |
| As at 30 June 2025 |
|
| As at 1 July 2024 |
|
|
Subsidary Undertaking
|
Registered Office
|
Nature of Business
|
Class of Share
|
Percentage of Shares held
|
|
Vector Brands Pty Ltd
|
Austrialia
|
Consumer healthcare
|
Ordinary
|
100
|
|
Vector Brands NZ Ltd
|
New Zealand
|
Consumer healthcare
|
Ordinary
|
100
|
| 2025 | 2024 | ||
|---|---|---|---|
| £ | £ | ||
| Stock |
|
|
|
| 2025 | 2024 | ||
|---|---|---|---|
| £ | £ | ||
| Due within one year | |||
| Trade debtors |
|
|
|
| Prepayments and accrued income |
|
|
|
| Other debtors |
|
|
|
|
|
|
||
| 2025 | 2024 | ||
|---|---|---|---|
| £ | £ | ||
| Net obligations under finance lease and hire purchase contracts |
|
|
|
| Trade creditors |
|
|
|
| Corporation tax | - |
|
|
| Other taxes and social security |
|
|
|
| VAT |
|
|
|
| Other creditors |
|
|
|
| Accruals and deferred income |
|
|
|
| Amounts owed to group undertakings |
|
|
|
|
|
|
||
| 2025 | 2024 | ||
|---|---|---|---|
| £ | £ | ||
| Net obligations under finance lease and hire purchase contracts |
|
|
|
| Other loans |
|
|
|
|
|
|
||
| 2025 | 2024 | ||
|---|---|---|---|
| £ | £ | ||
| Amounts falling due between one and five years: | |||
| Other loans | - |
|
|
| 2025 | 2024 | ||
|---|---|---|---|
| £ | £ | ||
| The future minimum finance lease payments are as follows: | |||
| Not later than one year |
|
|
|
| Later than one year and not later than five years |
|
|
|
|
|
|
||
|
|
|
||
| 2025 | 2024 | ||
|---|---|---|---|
| £ | £ | ||
| Other timing differences | 8,928 | - | |
| Deferred Tax | Total | |
|---|---|---|
| £ | £ | |
| Additions |
|
8,928 |
| Balance at 30 June 2025 |
|
8,928 |
|
Transaction value
|
Balance owed by / (owed) to
|
|||
|
2025
|
2024
|
2025
|
2024
|
|
|
£
|
£
|
£
|
£
|
|
|
Pharmapac (U.K.) Ltd
|
(60,000)
|
-
|
(3,237,737)
|
(1,503,804)
|